I understood from the company that a phase 3 trial of Cavatak and Yervoy would begin by the end of calendar 2018 at the earliest, my guess is that it would take at least 2 years to execute and probably another year to get approval.
If there is a chance of approval based on the in-flight phase 1/2 trial that would be great, but I can't see anyone (credible) saying that will happen.
VLA Price at posting:
82.0¢ Sentiment: Hold Disclosure: Held
